DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Mukka Proteins Limited — Updates

NSE 2 hrs ago·12 Aug 2026, 11:34 am

Mukka Proteins

Mukka Proteins Limited has informed stock exchanges that it will release its financial results for the quarter and the three months period ended June 30, 2026. This announcement confirms that the company will disclose its earnings, revenue, and other key financial metrics for the specified period.

Investors will closely monitor this release to assess the company's current financial health and performance. The results will provide insights into Mukka Proteins' operational efficiency, market position, and future growth prospects, which are critical for making informed investment decisions.

Market participants should watch for details on revenue growth, profit margins, and any commentary from management regarding future outlook. This update sets the stage for the company's next set of disclosures and investor discussions.